New Anti-VEGF Therapies for Neovascular Age-related
Macular Degeneration

This American Academy of Ophthalmology collection of activities provides ophthalmologists with a focused update on the latest data surrounding long-acting intravitreal anti-vascular endothelial growth factor (VEGF) therapies for neovascular age-related macular degeneration (nAMD).

Archived
Safety of the New Anti-VEGF Therapies: Findings From Treatment of nAMD

Safety of the New Anti-VEGF Therapies

Webinar
Credit Hours: 0.75 (45 min)
This activity has expired and is no longer available for credit

Switching to a New Anti-VEGF Agent for nAMD

Switching to a New Anti-VEGF Agent for nAMD

Patient Simulation
Credit Hours: 0.25 (15 min)
This activity has expired and is no longer available for credit

Initiating New Anti-VEGF Therapies in Patients With nAMD

Initiating New Anti-VEGF Therapies in Patients With nAMD

Patient Simulation
Credit Hours: 0.25 (15 min)
This activity has expired and is no longer available for credit

Translating the Latest Data for New Intravitreal Anti-VEGF Therapies to Treat nAMD in Clinical Practice

Translating the Latest Data for New Intravitreal Anti-VEGF Therapies

Webinar
Credit Hours: 0.75 (45 min)
This activity has expired and is no longer available for credit

Personalizing Treatment for nAMD Using New Anti-VEGF Therapies

Personalizing Treatment for nAMD Using New Anti-VEGF Therapies

Webinar
Credit Hours: 0.75 (45 min)
This activity has expired and is no longer available for credit

Extending Treatment Durability With Next-Generation nAMD Therapies

Extending Treatment Durability With Next-Generation nAMD Therapies

Webinar
Credit Hours: 0.50 (30 min)
This activity has expired and is no longer available for credit

Advances in Imaging nAMD and Approaches to Use of Long-Acting Anti-VEGF Therapies

Advances in Imaging nAMD and Approaches to Use of Long-Acting Anti-VEGF Therapies

Infographic
Credit Hours: 0.50 (30 min)
This activity has expired and is no longer available for credit

Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD

Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD

Case Consult
Credit Hours: 0.25 (15 min)
This activity has expired and is no longer available for credit

When to Start, When to Switch, and Dosing Strategy With Anti-VEGF Therapy

When to Start, When to Switch, and Dosing Strategy With Anti-VEGF Therapy

Case Consult
Credit Hours: 0.25 (15 min)
This activity has expired and is no longer available for credit

Success With Extended Dosing Intervals of Anti-VEGF Therapies for nAMD

Success With Extended Dosing Intervals of Anti-VEGF Therapies for nAMD

Case Consult
Credit Hours: 0.25 (15 min)
This activity has expired and is no longer available for credit

Strategies to Reduce Vision Loss in nAMD Using Long-Acting Anti-VEGF Therapies

Strategies to Reduce Vision Loss in nAMD Using Long-Acting Anti-VEGF Therapies

Patient Simulation
Credit Hours: 0.50 (30 min)
This activity has expired and is no longer available for credit